Antithrombin III for critically ill patients
M Allingstrup, J Wetterslev, FB Ravn… - Cochrane database …, 2016 - cochranelibrary.com
M Allingstrup, J Wetterslev, FB Ravn, AM Møller, A Afshari
Cochrane database of systematic reviews, 2016•cochranelibrary.comBackground Critical illness is associated with uncontrolled inflammation and vascular
damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an
anticoagulant with anti‐inflammatory properties but the efficacy and any harmful effects of AT
III supplementation in critically ill patients are unknown. This review was published in 2008
and updated in 2015. Objectives
damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an
anticoagulant with anti‐inflammatory properties but the efficacy and any harmful effects of AT
III supplementation in critically ill patients are unknown. This review was published in 2008
and updated in 2015. Objectives
Background
Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti‐inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown. This review was published in 2008 and updated in 2015.
Objectives
cochranelibrary.com